IMI BigData@Heart

  • IMI BigData@Heart

  • June 30th 2017
  • Preview

    Launched in March 2017, BigData@Heart is a five-year project of the Innovative Medicines Initiative (IMI), a public-private initiative between the European Union and the pharmaceutical industry association EFPIA.

    BigData@Heart aims to develop a data-driven translational research platform towards improving patient outcomes and therefore reducing the societal burden of Atrial Fibrillation (AF), Acute Coronary Syndrome (ACS) and Heart Failure (HF) in Europe.

  • Read more
  • Big Data for Better Hearts

  • March 07th 2017
  • Preview

    BigData@Heart is breaking new ground in the development of treatment for millions of patients with heart disease in Europe.


    The objective of BigData@Heart is to develop a data-driven translational research platform of unparalleled scale and phenotypical resolution, with the aim to improve patient outcomes and reduce the societal burden of atrial fibrillation, heart failure and acute coronary syndrome.


    The 19 partners of the BigData@Heart consortium, coming from academia, medical associations, the pharmaceutical industry, SMEs and patient organisations are:



    University Medical Center Utrecht
    Charité - Universitätsmedizin Berlin
    European Society of Cardiology
    European Heart Network
    University College London
    University of Cambridge
    International Consortium for Health Outcomes Measurement
    Fundación para la investigación del Hospital Clinico de la Comunidad Valenciana
    Karolinska Institutet
    Universitätsklinikum Hamburg-Eppendorf
    MLC Foundation
    University of Birmingham
    Uppsala Clinical Research Center, Uppsala University
    Vifor Pharma
    The Hyve


    Please click here for the BigData@Heart press release on this project.